Guidance Tool
How Can We Help You?
I’d like to...
Specifically...
Relevant Services and Products
Our Markets with Experience
-
MARKET
Health & National Security
Meet Our Experts
-
Corrie Carnes, Ph.D.
Program Manager IIDefense Solutions
Specializes in laboratory management, chemical and surface analysis, method development, and inorganic synthesis.
-
Charmel Grisham
Capability Manager IIDefense Solutions
Performs analytical chemistry to develop rapid chemical detection and gas chromatography technologies.
-
Gene Olinger, PhD, MBA
Distinguished Research FellowGlobal Health Surveillance and Diagnostics
Specializes in virology, immunology, and high-containment biodefense.
Insights
-
MRIGlobal Uses Data Viz Tools to Keep Warfighters Safe
This story was originally shared by Breaking Defense Special operators to deploy wearable to keep tabs on vitals, help warn about chemical threats The device is being developed by LifeLens Technologies and will detect warfighters’ physiological stressors in environments where there may be dangerous, even lethal substances in the environment. WASHINGTON – By the end […]
CBRNE Research & CTI Chemical Threats Software Development -
Three Measures to Radically Lower the Risk of a New H5N1 Pandemic
Kansas City, Mo.: (Aug. 5, 2025) – In a new Opinion paper in the Proceedings of the National Academy of Sciences titled “Three things we can do now to reduce the risk of avian influenza spillovers,” the authors call for three measures to radically lower the risk of a new influenza pandemic. These measures include […]
Biological Threats Biosurveillance & Threat Detection Health & National Security -
MRIGlobal Proud to Serve as Prime Contractor for Portable Biocontainment Unit
Kansas City, Mo.: (June 26, 2025) – MRIGlobal is proud to have served as prime contractor on development of two new Portable Biocontainment Units (PBCU), which were unveiled in May 2025 by the U.S. Department of Health and Human Services’ (HHS) Administration for Strategic Preparedness and Response (ASPR) during a ceremony in Washington, D.C. The […]
Biological Threats Engineering Mobile Laboratories & Patient Transport
Relevant Services and Products
Our Markets with Experience
-
MARKET
Health & National Security
Meet Our Experts
-
Charmel Grisham
Capability Manager IIDefense Solutions
Performs analytical chemistry to develop rapid chemical detection and gas chromatography technologies.
-
Keven Welch
Associate DirectorHealth Surveillance & Diagnostics Solutions
Leads global biosurveillance programs with over 20 years experience.
-
Gene Olinger, PhD, MBA
Distinguished Research FellowGlobal Health Surveillance and Diagnostics
Specializes in virology, immunology, and high-containment biodefense.
Insights
-
Three Measures to Radically Lower the Risk of a New H5N1 Pandemic
Kansas City, Mo.: (Aug. 5, 2025) – In a new Opinion paper in the Proceedings of the National Academy of Sciences titled “Three things we can do now to reduce the risk of avian influenza spillovers,” the authors call for three measures to radically lower the risk of a new influenza pandemic. These measures include […]
Biological Threats Biosurveillance & Threat Detection Health & National Security -
The Threat of Antimicrobial Resistance
There are potentially billions of different types of bacteria, and they’re found almost everywhere. Some are friends while others are foes. Studies show that kitchen sponges contain 45 billion bacteria per square centimeter. Another study suggests that your desktop has 400 times more bacteria than your toilet seat. And did you know that the average […]
Assay & Method Development Biosurveillance & Threat Detection Detection & Diagnostics -
Battling Antimicrobial Resistance
When an antibiotic treatment regimen is not successfully completed by a patient, the surviving bacteria have encountered the evolutionary pressure of the antibiotics that killed off a majority of their weaker population. These surviving, stronger bacteria are able to persist and continue growing inside the patient, eventually becoming strong enough to again cause symptoms. Because […]
Assay & Method Development Biosurveillance & Threat Detection Detection & Diagnostics
Relevant Services and Products
Our Markets with Experience
-
MARKET
RUO to IVD Product Development
Meet Our Experts
-
Karen Peltier, Ph.D.
Associate DirectorHealth Surveillance & Diagnostics Solutions
Supports targeted client solutions through strategic project planning and technical expertise.
-
Kristine Werking
Senior DirectorHealth Surveillance & Diagnostics Solutions
Leads multidisciplinary teams to support IVD solutions through development to market clearance.
-
Sharon Altmann
Biosafety & Biosecurity Capability ManagerHealth Surveillance & Diagnostics Solutions
Specializes in high-containment biosafety and biosecurity.
Insights
-
MRIGlobal Awarded a CDC Contract for up to $148 Million
Supports Rapid Development and Production of Emergency Response Diagnostic Tests
Assay & Method Development Biological Threats Biosurveillance & Threat Detection -
The Threat of Antimicrobial Resistance
There are potentially billions of different types of bacteria, and they’re found almost everywhere. Some are friends while others are foes. Studies show that kitchen sponges contain 45 billion bacteria per square centimeter. Another study suggests that your desktop has 400 times more bacteria than your toilet seat. And did you know that the average […]
Assay & Method Development Biosurveillance & Threat Detection Detection & Diagnostics -
Battling Antimicrobial Resistance
When an antibiotic treatment regimen is not successfully completed by a patient, the surviving bacteria have encountered the evolutionary pressure of the antibiotics that killed off a majority of their weaker population. These surviving, stronger bacteria are able to persist and continue growing inside the patient, eventually becoming strong enough to again cause symptoms. Because […]
Assay & Method Development Biosurveillance & Threat Detection Detection & Diagnostics
Relevant Services and Products
Our Markets with Experience
-
MARKET
Health & National Security
Meet Our Experts
-
Keven Welch
Associate DirectorHealth Surveillance & Diagnostics Solutions
Leads global biosurveillance programs with over 20 years experience.
-
Chris Hollars, Ph.D.
Senior Research FellowDefense Solutions
Directs large national security programs and oversees acquisition of specialized materials.
-
Corrie Carnes, Ph.D.
Program Manager IIDefense Solutions
Specializes in laboratory management, chemical and surface analysis, method development, and inorganic synthesis.
Insights
-
MRIGlobal Proud to Serve as Prime Contractor for Portable Biocontainment Unit
Kansas City, Mo.: (June 26, 2025) – MRIGlobal is proud to have served as prime contractor on development of two new Portable Biocontainment Units (PBCU), which were unveiled in May 2025 by the U.S. Department of Health and Human Services’ (HHS) Administration for Strategic Preparedness and Response (ASPR) during a ceremony in Washington, D.C. The […]
Biological Threats Engineering Mobile Laboratories & Patient Transport -
How Bad is H5N1?
Since the 1960s, a strain of influenza has impacted wild bird populations across North America. By 1997, it reached a poultry population in Hong Kong, and the first known humans were infected. By 2009, it was detected in commercial poultry in British Columbia, infecting more humans and killing 263. Today, a new variant is impacting […]
Biological Threats Biosurveillance & Threat Detection Detection & Diagnostics -
Agricultural Biosurveillance
With the goal of limiting disease spread among on-farm animals, agricultural biosurveillance can play a critical role. The H5N1 virus, more commonly known as avian influenza or “bird flu,” is spreading on farms in poultry and herds of dairy cows. Agricultural biosurveillance can support early detection by helping to gather, integrate, and interpret essential information […]
Biological Threats Biosurveillance & Threat Detection Detection & Diagnostics
Relevant Services and Products
Integrated drug development support from early research through clinical trial readiness
Read More
Our Markets with Experience
-
MARKET
Pharmaceutical
Meet Our Experts
-
Rachel Ginther, Ph.D.
Manager - BiologicsPharmaceutical Solutions
Leads the biologics team and serves as Principal Investigator on projects including analytical development, formulation development, and cGMP biopharmaceutical manufacturing.
-
Jami Larson
Assistant DirectorPharmaceutical Solutions
Leads pharmaceutical teams specializing in clinical trial material management, warehousing, and pharmaceutical stability facility operations.
-
John Cobb
Assistant DirectorPharmaceutical Solutions
Leads teams specializing in small molecule analytical, synthesis, API and drug product manufacturing.
Insights
-
MRIGlobal’s SCALE Center is a major part of the $34 Million Tech Hubs Award that the EDA intends to provide to the KC BioHub Consortium
Kansas City’s newest chapter in a long tradition of world-changing science: bringing life-saving medicines closer to the patients who need them.
Biologics Pharmaceutical -
Generic Drug Development
Generic pharmaceuticals make up nine out of every 10 prescriptions in the United States. And in 2025, drugs for COPD, hypertension, high cholesterol, cancer, and many other disease conditions have expiring patents, so can be produced as generics. These drugs are as effective and work the same as the name brands, but typically cost consumers […]
Clinical Trial Materials Management Drug Product Synthesis & API Manufacturing -
Demonstrating Generic Drug Equivalency
When a new pharmaceutical is in development and ready for clinical trials, the company that is producing it must file a New Drug Application (NDA). Conversely, when a generic is being produced, an Abbreviated New Drug Application (ANDA) must be filed. Through the ANDA, the manufacturer must demonstrate to the FDA that the new generic […]
Analytical Services Drug Product Pharmaceutical
Relevant Services and Products
Our Markets with Experience
-
MARKET
Pharmaceutical
Meet Our Experts
-
Rachel Ginther, Ph.D.
Manager - BiologicsPharmaceutical Solutions
Leads the biologics team and serves as Principal Investigator on projects including analytical development, formulation development, and cGMP biopharmaceutical manufacturing.
-
Reed Oshel
Assistant DirectorDefense Solutions
Leads MRIGlobal's materials and applied chemistry team.
-
Jonathan White, Ph.D.
Senior DirectorPharmaceutical Solutions
Directs integrated pharmaceutical solutions and cGMP drug product development.
Insights
-
MRIGlobal’s SCALE Center is a major part of the $34 Million Tech Hubs Award that the EDA intends to provide to the KC BioHub Consortium
Kansas City’s newest chapter in a long tradition of world-changing science: bringing life-saving medicines closer to the patients who need them.
Biologics Pharmaceutical -
Safeguarding a Clinical Trial Amid Regulatory and Logistical Constraints
Expertise enabled client to proceed without delay
Clinical Trial Materials Management Foreign-Trade Zone Warehouse & Distribution -
Trouble with Tariffs?
On Thursday, Sept. 25, President Trump announced 100% tariffs on some imported brand-name drugs starting October 1, unless manufacturers build U.S. plants to boost domestic production. As this new tariff policy is enacted, it may have an adverse impact on pharmaceutical companies by increasing the cost of importing raw materials, drug substances and drug products, […]
Clinical Trial Materials Management Foreign-Trade Zone Warehouse & Distribution
Relevant Services and Products
Our Markets with Experience
-
MARKET
RUO to IVD Product Development
-
MARKET
Pharmaceutical
Meet Our Experts
-
Karen Peltier, Ph.D.
Associate DirectorHealth Surveillance & Diagnostics Solutions
Supports targeted client solutions through strategic project planning and technical expertise.
-
Kristine Werking
Senior DirectorHealth Surveillance & Diagnostics Solutions
Leads multidisciplinary teams to support IVD solutions through development to market clearance.
-
Rachel Ginther, Ph.D.
Manager - BiologicsPharmaceutical Solutions
Leads the biologics team and serves as Principal Investigator on projects including analytical development, formulation development, and cGMP biopharmaceutical manufacturing.
Insights
-
MRIGlobal Awarded a CDC Contract for up to $148 Million
Supports Rapid Development and Production of Emergency Response Diagnostic Tests
Assay & Method Development Biological Threats Biosurveillance & Threat Detection -
The Threat of Antimicrobial Resistance
There are potentially billions of different types of bacteria, and they’re found almost everywhere. Some are friends while others are foes. Studies show that kitchen sponges contain 45 billion bacteria per square centimeter. Another study suggests that your desktop has 400 times more bacteria than your toilet seat. And did you know that the average […]
Assay & Method Development Biosurveillance & Threat Detection Detection & Diagnostics -
Battling Antimicrobial Resistance
When an antibiotic treatment regimen is not successfully completed by a patient, the surviving bacteria have encountered the evolutionary pressure of the antibiotics that killed off a majority of their weaker population. These surviving, stronger bacteria are able to persist and continue growing inside the patient, eventually becoming strong enough to again cause symptoms. Because […]
Assay & Method Development Biosurveillance & Threat Detection Detection & Diagnostics
Relevant Services and Products
Our Markets with Experience
-
MARKET
Pharmaceutical
Meet Our Experts
-
Karen Peltier, Ph.D.
Associate DirectorHealth Surveillance & Diagnostics Solutions
Supports targeted client solutions through strategic project planning and technical expertise.
-
Michaela Hoffmeyer
Senior Research FellowHealth Surveillance & Diagnostics Solutions
Drives market clearance of IVDs through regulatory and experienced clinical leadership.
-
Rachel Ginther, Ph.D.
Manager - BiologicsPharmaceutical Solutions
Leads the biologics team and serves as Principal Investigator on projects including analytical development, formulation development, and cGMP biopharmaceutical manufacturing.
Insights
-
Developing Investigational New Drug Applications
Pre-Clinical Data Supports Drug Clearance to Clinical Stage In brief, an Investigational New Drug (IND) application is like a permission slip from the FDA to initiate human testing of a new drug in the clinical stage. More technically, current Federal law requires that a drug be the subject of an approved marketing application before it […]
Drug Product IND-enabling strategy Pharmaceutical -
Consumer Product Testing and Evaluation Expertise
As a contract research organization (CRO) with a history of important breakthroughs in disease diagnostics, pharmaceutical science, and medical research, we are often tasked with addressing challenges at the forefront of scientific research – including consumer product testing.Because no two challenges are the same, our role is to adapt and seek solutions based on our […]
FDA Submissions Methods & Materials Testing & Evaluation
Relevant Services and Products
Our Markets with Experience
-
MARKET
Health & National Security
Meet Our Experts
-
Sharon Altmann
Biosafety & Biosecurity Capability ManagerHealth Surveillance & Diagnostics Solutions
Specializes in high-containment biosafety and biosecurity.
-
Lolly Gardiner, MBA, RBP, SM (NRCM), CBSP
Program ManagerHealth Surveillance & Diagnostics Solutions
Specializes in global biosafety and biosecurity engagement.
-
Corrie Carnes, Ph.D.
Program Manager IIDefense Solutions
Specializes in laboratory management, chemical and surface analysis, method development, and inorganic synthesis.
Insights
-
Laboratory Planning and Preparedness to Mitigate Risk
During the COVID-19 pandemic, the general public’s familiarity with the concept of risk assessment increased dramatically. For many of us, what had once been routine activities were abruptly scrutinized to determine whether and how they could be performed safely. Consider the act of buying groceries. Probably for the first time, you and other able-bodied, independently […]
Biosafety & Biosecurity Biosafety & Biosecurity Consulting - Laboratory Biosafety & Biosecurity Consulting - Strategy -
Biosafety and the Workplace
Biosafety is a discipline that is most often applied to work in the laboratory or to research-related activities. However, as the COVID-19 pandemic ramped up, organizations started to understand their risks in the workplace outside the laboratory and the applicability of biosafety became apparent. It was at this point that they called our team at […]
Biosafety & Biosecurity Biosafety & Biosecurity Consulting - Laboratory Biosafety & Biosecurity Consulting - Strategy -
Looming Challenges to Continuity
Beyond the COVID-19 pandemic, there are countless other looming challenges that could potentially disrupt the continuity of your day-to-day operations. By understanding which of these many diseases, natural disasters, and otherwise disruptive challenges may impact your operational continuity, you can be better prepared to mitigate those impacts. In each of these situations, there is potential […]
Biosafety & Biosecurity Biosafety & Biosecurity Consulting - Laboratory Biosafety & Biosecurity Consulting - Strategy
Relevant Services and Products
Our Markets with Experience
-
MARKET
Health & National Security
Meet Our Experts
-
Kris Schumacher
Research FellowDefense Solutions
Contributes to technical projects in diagnostics and national security.
-
Chris Hollars, Ph.D.
Senior Research FellowDefense Solutions
Directs large national security programs and oversees acquisition of specialized materials.
-
Corrie Carnes, Ph.D.
Program Manager IIDefense Solutions
Specializes in laboratory management, chemical and surface analysis, method development, and inorganic synthesis.
Insights
-
MRIGlobal Supports Wearable Hazard Monitoring Technology
Originally published by https://www.army.mil/ via cbrneworld.com. When warfighters are in the field, a multitude of factors impact their physical and cognitive abilities – threats in the environment, weather, how much food and water they’ve consumed – the list goes on. These factors can present additional obstacles that can hinder warfighters’ ability to maintain lethality and […]
Device Integration Software Development Health & National Security -
MRIGlobal Uses Data Viz Tools to Keep Warfighters Safe
This story was originally shared by Breaking Defense Special operators to deploy wearable to keep tabs on vitals, help warn about chemical threats The device is being developed by LifeLens Technologies and will detect warfighters’ physiological stressors in environments where there may be dangerous, even lethal substances in the environment. WASHINGTON – By the end […]
CBRNE Research & CTI Chemical Threats Software Development -
MRIGlobal Proud to Serve as Prime Contractor for Portable Biocontainment Unit
Kansas City, Mo.: (June 26, 2025) – MRIGlobal is proud to have served as prime contractor on development of two new Portable Biocontainment Units (PBCU), which were unveiled in May 2025 by the U.S. Department of Health and Human Services’ (HHS) Administration for Strategic Preparedness and Response (ASPR) during a ceremony in Washington, D.C. The […]
Biological Threats Engineering Mobile Laboratories & Patient Transport
Relevant Services and Products
Our Markets with Experience
-
MARKET
Pharmaceutical
Meet Our Experts
-
Jami Larson
Assistant DirectorPharmaceutical Solutions
Leads pharmaceutical teams specializing in clinical trial material management, warehousing, and pharmaceutical stability facility operations.
-
Rachel Ginther, Ph.D.
Manager - BiologicsPharmaceutical Solutions
Leads the biologics team and serves as Principal Investigator on projects including analytical development, formulation development, and cGMP biopharmaceutical manufacturing.
-
John Cobb
Assistant DirectorPharmaceutical Solutions
Leads teams specializing in small molecule analytical, synthesis, API and drug product manufacturing.
Insights
-
Safeguarding a Clinical Trial Amid Regulatory and Logistical Constraints
Expertise enabled client to proceed without delay
Clinical Trial Materials Management Foreign-Trade Zone Warehouse & Distribution -
Trouble with Tariffs?
On Thursday, Sept. 25, President Trump announced 100% tariffs on some imported brand-name drugs starting October 1, unless manufacturers build U.S. plants to boost domestic production. As this new tariff policy is enacted, it may have an adverse impact on pharmaceutical companies by increasing the cost of importing raw materials, drug substances and drug products, […]
Clinical Trial Materials Management Foreign-Trade Zone Warehouse & Distribution -
Generic Drug Development
Generic pharmaceuticals make up nine out of every 10 prescriptions in the United States. And in 2025, drugs for COPD, hypertension, high cholesterol, cancer, and many other disease conditions have expiring patents, so can be produced as generics. These drugs are as effective and work the same as the name brands, but typically cost consumers […]
Clinical Trial Materials Management Drug Product Synthesis & API Manufacturing
Relevant Services and Products
Our Markets with Experience
-
MARKET
Health & National Security
Meet Our Experts
-
Kris Schumacher
Research FellowDefense Solutions
Contributes to technical projects in diagnostics and national security.
-
Corrie Carnes, Ph.D.
Program Manager IIDefense Solutions
Specializes in laboratory management, chemical and surface analysis, method development, and inorganic synthesis.
-
Charmel Grisham
Capability Manager IIDefense Solutions
Performs analytical chemistry to develop rapid chemical detection and gas chromatography technologies.
Insights
-
MRIGlobal Supports Wearable Hazard Monitoring Technology
Originally published by https://www.army.mil/ via cbrneworld.com. When warfighters are in the field, a multitude of factors impact their physical and cognitive abilities – threats in the environment, weather, how much food and water they’ve consumed – the list goes on. These factors can present additional obstacles that can hinder warfighters’ ability to maintain lethality and […]
Device Integration Software Development Health & National Security -
Celebrating National Engineers Week
Sunday, Feb. 16 kicked off National Engineers Week and provides us the opportunity to celebrate how our engineers make a difference in the world. For more than 80 years, MRIGlobal’s scientific and engineering research contributions have been advancing knowledge and shaping the world. These are but two of our many engineers whom we celebrate. Aaron […]
Device Integration Engineering Mechanical Engineering -
Engineering is Everywhere
At MRIGlobal, engineering is everywhere. From one of our largest engineering projects with the Athena Mobile Laboratory to one of our smallest, the microfluidic device designed by Arjun Garapaty during his recent internship, and online projects like the Open Architecture Data Management System (OADMS) described in our 2022 Impact report. In doing so, we support […]
Engineering Mechanical Engineering Software Development
Relevant Services and Products
Our Markets with Experience
-
MARKET
Health & National Security
Meet Our Experts
-
Keven Welch
Associate DirectorHealth Surveillance & Diagnostics Solutions
Leads global biosurveillance programs with over 20 years experience.
-
Gene Olinger, PhD, MBA
Distinguished Research FellowGlobal Health Surveillance and Diagnostics
Specializes in virology, immunology, and high-containment biodefense.
-
Joseph Bogan, Jr., Ph.D.
Chief Research FellowResearch Operations
Leads research operations.
Insights
-
Three Measures to Radically Lower the Risk of a New H5N1 Pandemic
Kansas City, Mo.: (Aug. 5, 2025) – In a new Opinion paper in the Proceedings of the National Academy of Sciences titled “Three things we can do now to reduce the risk of avian influenza spillovers,” the authors call for three measures to radically lower the risk of a new influenza pandemic. These measures include […]
Biological Threats Biosurveillance & Threat Detection Health & National Security -
The Threat of Antimicrobial Resistance
There are potentially billions of different types of bacteria, and they’re found almost everywhere. Some are friends while others are foes. Studies show that kitchen sponges contain 45 billion bacteria per square centimeter. Another study suggests that your desktop has 400 times more bacteria than your toilet seat. And did you know that the average […]
Assay & Method Development Biosurveillance & Threat Detection Detection & Diagnostics -
Battling Antimicrobial Resistance
When an antibiotic treatment regimen is not successfully completed by a patient, the surviving bacteria have encountered the evolutionary pressure of the antibiotics that killed off a majority of their weaker population. These surviving, stronger bacteria are able to persist and continue growing inside the patient, eventually becoming strong enough to again cause symptoms. Because […]
Assay & Method Development Biosurveillance & Threat Detection Detection & Diagnostics
Relevant Services and Products
Our Markets with Experience
-
MARKET
RUO to IVD Product Development
Meet Our Experts
-
Karen Peltier, Ph.D.
Associate DirectorHealth Surveillance & Diagnostics Solutions
Supports targeted client solutions through strategic project planning and technical expertise.
-
Michaela Hoffmeyer
Senior Research FellowHealth Surveillance & Diagnostics Solutions
Drives market clearance of IVDs through regulatory and experienced clinical leadership.
-
Kristine Werking
Senior DirectorHealth Surveillance & Diagnostics Solutions
Leads multidisciplinary teams to support IVD solutions through development to market clearance.
Insights
-
MRIGlobal Awarded a CDC Contract for up to $148 Million
Supports Rapid Development and Production of Emergency Response Diagnostic Tests
Assay & Method Development Biological Threats Biosurveillance & Threat Detection -
The Threat of Antimicrobial Resistance
There are potentially billions of different types of bacteria, and they’re found almost everywhere. Some are friends while others are foes. Studies show that kitchen sponges contain 45 billion bacteria per square centimeter. Another study suggests that your desktop has 400 times more bacteria than your toilet seat. And did you know that the average […]
Assay & Method Development Biosurveillance & Threat Detection Detection & Diagnostics -
Battling Antimicrobial Resistance
When an antibiotic treatment regimen is not successfully completed by a patient, the surviving bacteria have encountered the evolutionary pressure of the antibiotics that killed off a majority of their weaker population. These surviving, stronger bacteria are able to persist and continue growing inside the patient, eventually becoming strong enough to again cause symptoms. Because […]
Assay & Method Development Biosurveillance & Threat Detection Detection & Diagnostics
Relevant Services and Products
Our Markets with Experience
-
MARKET
RUO to IVD Product Development
-
MARKET
Health & National Security
Meet Our Experts
-
Keven Welch
Associate DirectorHealth Surveillance & Diagnostics Solutions
Leads global biosurveillance programs with over 20 years experience.
-
Karen Peltier, Ph.D.
Associate DirectorHealth Surveillance & Diagnostics Solutions
Supports targeted client solutions through strategic project planning and technical expertise.
-
Corrie Carnes, Ph.D.
Program Manager IIDefense Solutions
Specializes in laboratory management, chemical and surface analysis, method development, and inorganic synthesis.
Insights
-
MRIGlobal Proud to Serve as Prime Contractor for Portable Biocontainment Unit
Kansas City, Mo.: (June 26, 2025) – MRIGlobal is proud to have served as prime contractor on development of two new Portable Biocontainment Units (PBCU), which were unveiled in May 2025 by the U.S. Department of Health and Human Services’ (HHS) Administration for Strategic Preparedness and Response (ASPR) during a ceremony in Washington, D.C. The […]
Biological Threats Engineering Mobile Laboratories & Patient Transport -
Celebrating International Day of Women & Girls in Science
Tuesday, February 11, is International Day of Women & Girls in Science and allows us to honor women’s significant achievements in science and place a much-needed focus on girls entering Science, Technology, Engineering, and Mathematics (STEM) careers. For more than 80 years, MRIGlobal’s scientific research contributions have been advancing knowledge and shaping the world. These […]
CBRNE Research & CTI Field-Forward Pathogen Detection Synthesis & API Manufacturing -
Agnostic Detection Challenges and Opportunities
Because of the importance of speed in responding to emerging public health threats, agnostic detection can play an important role in strengthening surveillance globally. While traditional detection techniques are target specific, agnostic detection methods are unbiased approaches that can surveil the environment to detect a broad range of pathogens, such as viruses, bacteria, and fungi, […]
Bioinformatics & Data Science Biological Threats Biosurveillance & Threat Detection
Relevant Services and Products
Our Markets with Experience
-
MARKET
Health & National Security
-
MARKET
RUO to IVD Product Development
Meet Our Experts
-
Corrie Carnes, Ph.D.
Program Manager IIDefense Solutions
Specializes in laboratory management, chemical and surface analysis, method development, and inorganic synthesis.
-
Charmel Grisham
Capability Manager IIDefense Solutions
Performs analytical chemistry to develop rapid chemical detection and gas chromatography technologies.
-
Reed Oshel
Assistant DirectorDefense Solutions
Leads MRIGlobal's materials and applied chemistry team.
Insights
-
Should I Be Concerned About Tuberculosis?
In August 2025, new tuberculosis cases have been detected in Northern California and Washington, prompting concern for those infected and about its possible further spread in those communities. But should you be concerned? Previously in January 2025, an ongoing tuberculosis (TB) outbreak in Kansas became one of the largest outbreaks in U.S. history, dating back […]
Biological Threats Product Development Verification & Validation -
Decontamination Efficacy Validations for Clandestine Laboratory Remediation Impetus for a standard
Access the Dec. 2024 issue of CBRNeWorld here and read “Decontamination Efficacy Validations for Clandestine Laboratory Remediation Impetus for a standard” by Evan Durnal on page 25. The goal for remediation of any clandestine drug production, distribution, and use site is a rapid return to normalcy. Since these sites include public ports, private homes, single […]
CBRNE Research & CTI Chemical Threats Testing & Evaluation -
MRIGlobal plays key role in developing new Covid/flu at-home test
By Grace Mayer – Staff Writer, Kansas City Business Journal Dec 9, 2024 A Kansas City-based research organization was a key player in bringing to market a new at-home test that – for the first time – can help people determine if they have Covid-19 or either of the two primary forms of flu. MRIGlobal, […]
Assay & Method Development Biological Threats Product Development
Solutions for a Safer, Healthier World
Leveraging decades of experience and an unbiased approach, we deliver solutions to complex challenges, even in the most demanding environments.
Why MRIGlobal?
We Are Mission-Driven and Deliver Trusted Results
For more than 80 years, MRIGlobal has made the world healthier and safer through applied scientific and engineering research. As an independent nonprofit, we integrate multidisciplinary expertise to solve complex challenges and deliver trusted results in global health and national security.
Our People
Direct Collaboration. Quality Outcomes.
Throughout every client engagement, we provide direct, ongoing access to the subject matter experts on our dedicated project teams to ensure clarity and precision within rapidly shifting landscapes.
Insights Into Complex Challenges
Explore expert perspectives, technical insights, and applied research on emerging threats, scientific advancement, and operational challenges.
Latest from the Blog
-
Peters to Present on Vapor Generation at ACS
Develops and characterizes reliable methods for generating chemical agent vapors
CBRNE Research & CTI Chemical Threats Library Development -
A Tour of the New MRIGlobal Website
MRIGlobal's New Website
-
MRIGlobal’s SCALE Center is a major part of the $34 Million Tech Hubs Award that the EDA intends to provide to the KC BioHub Consortium
Kansas City’s newest chapter in a long tradition of world-changing science: bringing life-saving medicines closer to the patients who need them.
Biologics Pharmaceutical
